1-5 of 5
Maria-Teresa Bernal
Close
Sort by
Journal Articles

Comparison of Short-Term Outcomes Between CSTIBES02 and ALL Ph08 Trials for Young Patients with Philadephia Chromosome-Positive ALL (Ph+ALL) Differing In Imatinib Dose and Amount of Chemotherapy Before Stem Cell Transplantation

Josep-Maria Ribera, MD, PhD, Olga Garcia, PhD, Pau Montesinos, MD, Manuel Barrios, Albert Oriol, Salut Brunet, Jose Gonzalez, MD, Jordi Esteve, MD, Mar Tormo, Eloy Del Potro, MD, Maria-José Moreno, Pascual Fernández-Abellán, Jesú S. M.a Hernández-Rivas, MD, PhD, Pere Barba, MD, Josep Sarrá, Eugènia Abella, Maria-Teresa Bernal, Andreu Llorente, Maria-Luz Amigo, Esperanza Lavilla, Pilar Bravo, Miguel-Angel Sanz, MD, Evarist Feliu, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2582.
https://doi.org/10.1182/blood.V118.21.2582.2582
Published: 2011
Journal Articles

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial Including the Use of Propensity Score (PS) Method to Reduce Assignment Bias.

Josep-Maria Ribera, Albert Oriol, Mireia Morgades, Miguel-Angel Sanz, Pau Montesinos, Josep Sarra, Salut Brunet, Pascual Fernández-Abellan, Ramon Guardia, Jordi Esteve, Jose Gonzalez-Campos, Arancha Bermudez, Maria-Jose Moreno, Maria-Teresa Bernal, Mar Tormo, Eloy Del Potro, Antonia Cladera, Andreu Llorente, Raimundo Garcia-Boyero, Maria-Jose Rabuñal, Juan Bergua, Carlos Grande, Maria-Luz Amigo, Javier Bueno, Concepcion Bethencourt, Jesus-Maria Hernandez-Rivas, Evarist Feliu
Journal: Blood
Blood (2009) 114 (22): 322.
https://doi.org/10.1182/blood.V114.22.322.322
Published: 2009
Journal Articles

Azacitidine Is Effective in Patients with Low / Intermediate-1 Risk Myelodysplastic Syndrome Managed in Community Based Practice: Preliminary Data From the Spanish Compassionate Use Registry.

Regina Garcia, MD, Dunia de Miguel, MD, Maria-Teresa Bernal, MD, Mar Tormo, MD, Guillermo Sanz, Raquel de Paz, MD, PhD, Antonio Figueredo, MD, Maria E Amutio, MD, José L. Guzmán, MD
Journal: Blood
Blood (2009) 114 (22): 3801.
https://doi.org/10.1182/blood.V114.22.3801.3801
Published: 2009
Journal Articles

Secondary Malignancies after Autologous Stem Cell Transplantation for Hodgkin’s Lymphoma: Incidence and Analysis of Risk Factors.

Mireia Constans, Anna Sureda, Reyes Arranz, Maria Dolores Caballero, Juan Jose Lahuerta, Juan Carlos Hernandez-Boluda, Maria Jesus Vidal, Jose Garcia-Laraña, Jose Rifon, Josep Maria Ribera, Pascual Fernandez-Abellan, Jose Maria Moraleda, Maria Teresa Bernal, Maria Victoria Mateos, Maria Martin-Mateos, Rafael Cordoba, Javier Garcia-Conde, Jorge Sierra, Eulogio Conde, for the Spanish Cooperative Group (GEL/TAMO).
Journal: Blood
Blood (2004) 104 (11): 60.
https://doi.org/10.1182/blood.V104.11.60.60
Published: 2004
Journal Articles

Prognostic Factors and Long-Term Outcome for Patients with Hodgkin’s Lymphoma Who Relapse after an Autologous Stem Cell Transplantation.

Mireia Constans, Anna Sureda, Reyes Arranz, Maria Dolores Caballero, Juan Jose Lahuerta, Juan Carlos Hernandez-Boluda, Maria Jesus Vidal, Jose Garcia-Laraña, Jose Rifon, Josep Maria Ribera, Pascual Fernandez-Abellan, Jose Maria Moraleda, Maria Teresa Bernal, Maria Victoria Mateos, Maria Martin-Mateos, Rafael Cordoba, Javier Garcia-Conde, Jorge Sierra, Eulogio Conde, for the Spanish Cooperative Group GEL/TAMO
Journal: Blood
Blood (2004) 104 (11): 1649.
https://doi.org/10.1182/blood.V104.11.1649.1649
Published: 2004